EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan

Malika E Khodjaeva iD, Aziza S Khikmatullaeva, Nargiz S Ibadullaeva, Gulnara K Khudaykulova, Munisa M Ilyasova, Kamila U Eshbayeva, Dildorakhon N Abdurakhmanova, Helenie Kefalakes iD, Petra Huber, Michael J Gebel, Erkin I Musabaev, Heiner Wedemeyer iD und 1 weitere

Liver International · 2026

DOI: 10.1111/liv.70799 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Malika E Khodjaeva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Research Institute of Virology, Tashkent, Uzbekistan. Hauptthemen laut MEDLINE: Hepatitis D, Chronic, Coinfection, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Gesellschaft für Internationale Zusammenarbeit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Chronic hepatitis B virus (HBV) infection is endemic in Uzbekistan. Previous data showed a high prevalence of anti‐hepatitis D virus (HDV) antibodies in HBsAg‐positive individuals. Limited data are available on disease severity, treatment availability and hepatocellular carcinoma (HCC) prevalence in patients with chronic HDV infection in Uzbekistan.

Methods

The Scientific Research Institute of Virology (SRIoV) is the leading medical and scientific reference centre for viral hepatitis in Uzbekistan. In this retrospective study, epidemiological, clinical and laboratory data were collected and analysed from all HBsAg‐positive patients presenting to the SRIoV between June 2023 and May 2024. Data from HDV‐coinfected and HBV‐monoinfected patients were compared.

Results

Data of 1393 individual patients were included. HDV coinfection was more prevalent than HBV‐monoinfection (73.9% [ n = 1030/1393]) vs. 26.1% [ n = 363/1393]. HDV‐infected patients were significantly younger (41.9 vs. 45.4, p < 0.001) and showed higher rates of cirrhosis (78.4% vs. 43.9%, p < 0.001) with the majority of patients being classified as Child–Pugh score B (57.8%). Only a minority of HDV‐coinfected patients has ever received anti‐HDV‐directed treatment (0.4%, n = 4/1030). Consecutively, HDV RNA was detectable in 78.9% (812/1023) of patients. Quantitative HDV RNA was independently associated with ALT elevation > upper limit of normal. The HCC detection rate was low in both patient groups due to insufficient screening measures (HDV: n = 7/1030, HBV: n = 11/363).

Conclusions

In this retrospective cohort of 1393 individual patients, HDV coinfection exceeds HBV monoinfection in prevalence and disease severity. Most HDV‐infected patients present with advanced liver disease and currently lack access to HDV‐directed therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis D, ChronicCoinfectionLiver NeoplasmsCarcinoma, HepatocellularHepatitis B, ChronicLiver CirrhosisHumansUzbekistanRetrospective StudiesMaleFemalePrevalenceAdultMiddle AgedHepatitis Delta VirusHepatitis B Surface AntigensSeverity of Illness Index

Stichwörter der Autor:innen

CHDCentral AsiaHCCHDVhepatitis delta

Substanzen

Hepatitis B Surface Antigens

Autor:innen und Institutionen

  • Scientific Research Institute of Virology, Tashkent, Uzbekistan.
  • Tashkent Medical State University, Tashkent, Uzbekistan.
  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • D-SOLVE Consortium, an EU Horizon Europe-Funded Project (No 101057917), Hannover, Germany.
  • Excellence Cluster RESIST, Excellence Initiative, Excellence Initiative Hannover Medical School, Hannover, Germany.
  • German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany.

ORCID-Profile: Malika E Khodjaeva, Helenie Kefalakes, Heiner Wedemeyer

Förderung

  • Deutsche Gesellschaft für Internationale Zusammenarbeit

Zitieren

APA

Khodjaeva, M. E., Khikmatullaeva, A. S., Ibadullaeva, N. S., Khudaykulova, G. K., Ilyasova, M. M., Eshbayeva, K. U., Abdurakhmanova, D. N., Kefalakes, H., Huber, P., Gebel, M. J., Musabaev, E. I., Wedemeyer, H., & Sandmann, L. (2026). High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan. Liver International. https://doi.org/10.1111/liv.70799

Vancouver

Khodjaeva ME, Khikmatullaeva AS, Ibadullaeva NS, Khudaykulova GK, Ilyasova MM, Eshbayeva KU, et al. High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan. Liver International. 2026. doi:10.1111/liv.70799

BibTeX
@article{Khodjaeva2026,
  author = {Khodjaeva, Malika E and Khikmatullaeva, Aziza S and Ibadullaeva, Nargiz S and Khudaykulova, Gulnara K and Ilyasova, Munisa M and Eshbayeva, Kamila U and Abdurakhmanova, Dildorakhon N and Kefalakes, Helenie and Huber, Petra and Gebel, Michael J and Musabaev, Erkin I and Wedemeyer, Heiner and Sandmann, Lisa},
  title = {High Rates of Advanced Chronic Liver Disease in Patients With Chronic Hepatitis D Virus Infection in Uzbekistan},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70799}
}
Kostenlos starten →